title: The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia.
authors.forename: Ying-Jay
authors.initials: YJ
authors.lastname: Liou
authors.forename: I-Ching
authors.initials: IC
authors.lastname: Lai
authors.forename: Ding-Lieh
authors.initials: DL
authors.lastname: Liao
authors.forename: Jen-Yeu
authors.initials: JY
authors.lastname: Chen
authors.forename: Chao-Cheng
authors.initials: CC
authors.lastname: Lin
authors.forename: Chih-Yuan
authors.initials: CY
authors.lastname: Lin
authors.forename: Chun-Ming
authors.initials: CM
authors.lastname: Chen
authors.forename: Ya-Mei
authors.initials: YM
authors.lastname: Bai
authors.forename: Tzu-Ting
authors.initials: TT
authors.lastname: Chen
authors.forename: Ying-Chieh
authors.initials: YC
authors.lastname: Wang
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects; D016022:Case-Control Studies; D004409:Dyskinesia, Drug-Induced / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D012559:Schizophrenia / Q000188:drug therapy; D012694:Serine / Q000235:genetics
chemical_list: D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2; D012694:Serine